Postmenopausal estrogen therapy and selected (less-often-considered) disease outcomes

Menopause

Volumn 6, Issue 1, 1999, Pages 14-20

  Barrett Connor, Elizabeth ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Arthritis; Asthma; Cataracts; Cholecystitis; Diabetes; Migraine; Raynaud's syndrome; Systemic lupus erythematosus; Urinary tract infection; Venous thromboembolic disease

Indexed keywords

ESTROGEN;

ARTICLE; ASTHMA; CATARACT; CHOLECYSTITIS; DIABETES MELLITUS; DISEASE ASSOCIATION; ESTROGEN THERAPY; FEMALE; HORMONAL REGULATION; HUMAN; MIGRAINE; POSTMENOPAUSE; RAYNAUD PHENOMENON; RHEUMATOID ARTHRITIS; RISK BENEFIT ANALYSIS; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; URINARY TRACT INFECTION; VEIN THROMBOSIS;

EID: 0033036368     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042192-199906010-00005     Document Type: Article

References (2)

1. Ettinger B. Overview of estrogen replacement therapy: a historical perspective. Proc Soc Exp Biol Med 1998; 217:2-5.
2. Barrett-Connor E, Grady D. Hormone replacement therapy, heart disease and other considerations. Annu Rev Public Health 1998;19:55-72.